go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Eli Lilly and Company (Ireland) Limited
Hyde House, 65, Adelaide Road, Dublin 2,
Telephone: +353 1 661 4377
Fax: +353 1 661 4476
WWW: http://www.lilly.ie
Medical Information Direct Line: +44 (0)1256 315 000
Medical Information Facsimile: +44 (0)1256 775 569
Patient Information Leaflet last updated on medicines.ie: 01/08/2011
PIL Yentreve

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 01/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to further information section
  • Change to date of revision
Updated on 14/02/2011 and displayed until 01/08/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
Updated on 07/10/2010 and displayed until 14/02/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
Updated on 25/08/2009 and displayed until 07/10/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to further information section
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
Updated on 19/09/2007 and displayed until 25/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to instructions about overdose
  • Change due to harmonisation of patient information leaflet
  • Change to date of revision
Updated on 10/01/2007 and displayed until 19/09/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/01/2007 and displayed until 10/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to date of revision
Updated on 22/06/2006 and displayed until 05/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 05/12/2005 and displayed until 22/06/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 15/11/2005 and displayed until 05/12/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/09/2004 and displayed until 15/11/2005
Reasons for adding or updating:
  • New PIL for medicines.ie
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  duloxetine hydrochloride